Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer - Concepedia

Concepedia

Publication | Open Access

Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer

DOI Full Paper Access

58

Citations

29

References

2022

Year

Johan Maertens, Tom Lodewyck, J. Peter Donnelly, Sylvain Chantepie, Christine Robin, Nicole M. A. Blijlevens, Pascal Turlure, Dominik Selleslag, Frédéric Baron, Mickaël Aoun,

Clinical Infectious Diseases

Abstract

The preemptive antifungal strategy was safe for high-risk neutropenic patients given fluconazole as prophylaxis, halving the number of patients receiving antifungals without excess mortality or IFDs. Clinical Trials Registration. NCT01288378; EudraCT 2010-020814-27.

References

	Year	Citations

Page 1